Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China
Yang, Yuan; Ge, Hongmin; Wang, Xijin; Liu, Xuejun; Li, Keqing; Wang, Gang; Yang, Xiaodong; Deng, Huaili; Sun, Meijuan; Zhang, Ruiling; Chen, Jindong; Cai, Duanfang; Sang, Hong; Liu, Xianglai; Zhan, Guilai; Zhao, Guijun; Li, Haiyun; Xun, Zhiyuan Share Save A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorderZhao, Qian; Fu, Bingbing; Lyu, Nan; Xu, Xiangdong; Huang, Guangbiao; Tan, Yunlong; Xu, Xiufeng; Zhang, Xuehua; Wang, Xueyi; Wang, Zhiqiang; Li, Keqing; Hu, ZhenYu; Li, Hengfen; He, Hongbo; Li, Shuang; Zhao, Jingyuan; He, Ruifeng; Guo, Hua; Li, Yi; Li, Lehua; Yang, Chuang; Zou, Shaohong; Wei, Bo; Wang, Wenqiang; Chen, Ce; Lu, Zheng; He, Shunqiang; Wang, Qian; Zhao, Jinghua; Pan, Xiaoyue; Pan, Zhenyu; Li, Junqing; Wang, Gang Share Save The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled studyWu, Yaxue; Li, Yanli; Liang, Weiye; Bai, Luyuan; Yu, Jianjin; Li, Keqing; Zhang, Yunshu; Guo, Yanmei; Liu, Zenglong; Wang, Jian; Zhang, Congpei; Wang, Xijin; Xu, Jia; Liu, Liping; Li, Juan; Yang, Fude Share Save Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillanceBo, Qijing; Wang, Xijin; Liu, Xuejun; Sang, Hong; Xun, Zhiyuan; Zhang, Ruiling; Yang, Xiaodong; Deng, Huaili; Li, Keqing; Chen, Jindong; Sun, Meijuan; Zhao, Guijun; Liu, Xianglai; Cai, Duanfang; Zhan, Guilai; Li, Juhong; Li, Haiyun; Wang, Gang Share Save Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing SurveillanceWu, Haishan; Wang, Xijin; Liu, Xuejun; Sang, Hong; Bo, Qijing; Yang, Xiaodong; Xun, Zhiyuan; Li, Keqing; Zhang, Ruiling; Sun, Meijuan; Cai, Duanfang; Deng, Huaili; Zhao, Guijun; Li, Juhong; Liu, Xianglai; Zhan, Guilai; Chen, Jindong Share Save Share Save Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority studyXiao, Le; Zhao, Qian; Li, An-ning; Sun, Jushui; Wu, Bin; Wang, Lina; Zhang, Honggeng; Zhang, Ruiling; Li, Keqing; Xu, Xiaojin; Liu, Tiebang; Zhang, Wenshun; Xie, Shiping; Xu, Xiufeng; Tan, Yunlong; Zhang, Kerang; Zhang, Hongyan; Guan, Nianhong; Xian, Mingji; Uki, Motomichi; Wang, Gang Share Save Share Save Share Save Longitudinal trajectory analysis of antipsychotic response in patients with schizophrenia: 6-week, randomised, open-label, multicentre clinical trial (vol 6, e126, 2020)Dai, Minhan; Wu, Yulu; Tang, Yiguo; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Deng, Wei; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Hu, Xun; Zhang, Guangya; Du, Xiaodong; Wang, Qiang; Li, Tao Share Save Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophreniaSu, Yi; Yu, Hao; Wang, Zhiren; Liu, Sha; Zhao, Liansheng; Fu, Yingmei; Yang, Yongfeng; Du, Bo; Zhang, Fuquan; Zhang, Xiangrong; Huang, Manli; Hou, Cailan; Huang, Guoping; Su, Zhonghua; Peng, Mao; Yan, Ran; Zhang, Yuyanan; Yan, Hao; Wang, Lifang; Lu, Tianlan; Jia, Fujun; Li, Keqing; Lv, Luxian; Wang, Hongxing; Yu, Shunying; Wang, Qiang; Tan, Yunlong; Xu, Yong; Zhang, Dai; Yue, Weihua Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
